顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > グローバル子供用混合ワクチン市場規模、主要企業シェア、ランキング分析レポート【2026年版】

グローバル子供用混合ワクチン市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Combination Vaccines for Children - Global Top Players Market Share and Ranking 2026
  • レポートID：
    259926
  • 発表時期：
    2026-03-13
  • レポート形式：
    PDF
  • 産業カテゴリー：
    医療機器と消耗材
  • レポート言語：
    英語、日本語
  • ページ数：
    115
  • 発行会社（調査会社）：
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界の子供用混合ワクチン市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から子供用混合ワクチン市場を分析し、需要構造と成長特性を明確化します。
子供用混合ワクチン市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、子供用混合ワクチンに関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要子供用混合ワクチン市場の統計
2025年世界市場規模：6826百万米ドル
2026年世界市場規模：7352百万米ドル
2032年予測市場規模：11117百万米ドル
2026–2032年予測期間CAGR：7.1%
本レポートは子供用混合ワクチン市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
子供用混合ワクチン市場の主要企業には以下が含まれます：
GlaxoSmithKline (GSK)
Merck
KM Biologics
Walvax Biotechnology
Biokangtai
Sinovac
Sanofi
Serum Institute of India
Biological E.
Panacea Biotec
Bharat Biotech
LG Chem
PT Bio Farma 

製品別
Bivalent Type
Trivalent Type
Multivalent Type (≥4 Valents) 

アプリケーション別
Routine Childhood Immunization
Public Health
Private Medical 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
子供用混合ワクチン市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
子供用混合ワクチン市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に子供用混合ワクチン市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に子供用混合ワクチン市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、子供用混合ワクチン市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、子供用混合ワクチン市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
子供用混合ワクチン市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 子供用混合ワクチン市場の全体像と成長見通し
子供用混合ワクチン市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が子供用混合ワクチン市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
子供用混合ワクチン産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
子供用混合ワクチン市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から子供用混合ワクチン市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
子供用混合ワクチン市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
子供用混合ワクチン市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Combination Vaccines for Children should grow from US$ 6826 million in 2025 to US$ 11117 million by 2032, with a CAGR of 7.1% for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.
In 2025, global Combination Vaccines for Children production reached approximately 535 M Doses, with an average global market price of around 12 US$/dose.

Combination Vaccines for Children are specialized immunization products designed for infants and children, formulated by combining antigens of multiple pathogenic microorganisms (such as bacteria, viruses) into a single vaccine. These vaccines are scientifically developed to trigger a protective immune response against multiple diseases simultaneously, reducing the number of injections children need to receive during the critical immunization period (0-6 years old). They strictly comply with national and international immunization standards, ensuring safety, efficacy, and compatibility of the combined antigens, and cover common childhood diseases such as diphtheria, tetanus, pertussis, polio, hepatitis B, and Haemophilus influenzae type b (Hib). As a core part of childhood immunization programs, they not only improve vaccination compliance but also reduce the burden on children, parents, and medical institutions, playing a vital role in preventing childhood infectious diseases.

The market demand for Combination Vaccines for Children maintains steady and rapid growth, driven by the global emphasis on childhood immunization, the popularization of national immunization programs, and the increasing demand for convenient, safe, and efficient vaccination solutions, creating substantial business opportunities. Demand is primarily fueled by government-led immunization programs, private medical institutions, and parents’ growing awareness of child health, with emerging markets showing stronger growth potential due to improving medical infrastructure and rising per capita income. Business opportunities lie in R&D of multi-valent combination vaccines covering more childhood diseases, optimizing formulations to improve safety and efficacy (such as reducing side effects), expanding production capacity to meet growing market demand, and cooperating with governments and international health organizations to participate in immunization programs, especially tapping into the untapped potential of emerging markets with insufficient vaccine coverage.

This report studies and analyses global Combination Vaccines for Children status and future trends, helps the client to determine the Combination Vaccines for Children market size of the total market opportunity by Valence, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Combination Vaccines for Children, and provides market size (in M Doses & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Combination Vaccines for Children market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (M Doses)
(2) Global Combination Vaccines for Children sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (M Doses)
(3) Japan Combination Vaccines for Children sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (M Doses)
(4) Global Combination Vaccines for Children key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Combination Vaccines for Children key producing regions, capacity, production, and year over year growth
(6) Combination Vaccines for Children industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    GlaxoSmithKline (GSK)
    Merck
    KM Biologics
    Walvax Biotechnology
    Biokangtai
    Sinovac
    Sanofi
    Serum Institute of India
    Biological E.
    Panacea Biotec
    Bharat Biotech
    LG Chem
    PT Bio Farma

Market segment by Valence, covers
    Bivalent Type
    Trivalent Type
    Multivalent Type (≥4 Valents)

Market segment by Pathogen Type, covers
    Bacterial-Viral Combined
    Bacterial-Bacterial Combined
    Viral-Viral Combined

Market segment by Administration Route, covers
    Intramuscular Injection
    Subcutaneous Injection
    Oral Combined

Market segment by Application, can be divided into
    Routine Childhood Immunization
    Public Health
    Private Medical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Combination Vaccines for Children product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Combination Vaccines for Children market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Combination Vaccines for Children market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Combination Vaccines for Children, percent & CAGR, 2021-2032
Chapter 5: Combination Vaccines for Children industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Valence, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions
title

Table of Contents

1 Market Overview
    1.1 Combination Vaccines for Children Definition
    1.2 Global Combination Vaccines for Children Market Size and Forecast
        1.2.1 By Consumption Value, Global Combination Vaccines for Children Market Size, 2021-2032
        1.2.2 By Sales Quantity, Global Combination Vaccines for Children Market Size, 2021-2032
        1.2.3 Global Combination Vaccines for Children Average Selling Price (ASP), 2021-2032
    1.3 Japan Combination Vaccines for Children Market Size and Forecast
        1.3.1 By Consumption Value, Japan Combination Vaccines for Children Market Size, 2021-2032
        1.3.2 By Sales Quantity, Japan Combination Vaccines for Children Market Size, 2021-2032
        1.3.3 Japan Combination Vaccines for Children Average Selling Price (ASP), 2021-2032
    1.4 Share of Japan Combination Vaccines for Children Market with Respect to the Global Market
        1.4.1 By Consumption Value, Japan Combination Vaccines for Children Market Share in Global, 2021-2032
        1.4.2 By Sales Quantity, Japan Combination Vaccines for Children Market Share in Global, 2021-2032
        1.4.3 Combination Vaccines for Children Market Size: Japan VS Global, 2021-2032
    1.5 Combination Vaccines for Children Market Dynamics
        1.5.1 Combination Vaccines for Children Market Drivers
        1.5.2 Combination Vaccines for Children Market Restraints
        1.5.3 Combination Vaccines for Children Industry Trends
        1.5.4 Combination Vaccines for Children Industry Policy
2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of Combination Vaccines for Children, Global Market Share by Company, 2021-2026
    2.2 By Sales Quantity of Combination Vaccines for Children, Global Market Share by Company, 2021-2026
    2.3 Combination Vaccines for Children Average Selling Price (ASP) by Company, 2021-2026
    2.4 Global Combination Vaccines for Children Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Combination Vaccines for Children Concentration Ratio
    2.6 Global Combination Vaccines for Children Mergers & Acquisitions, Expansion Plans
    2.7 Global Combination Vaccines for Children Manufacturers Product Type
    2.8 Head Office and Combination Vaccines for Children Production Site of Key Manufacturer
    2.9 Combination Vaccines for Children Capacity of Major Manufacturers and Future Plan
3 Japan Leading Manufacturers and Market Share
    3.1 By Revenue of Combination Vaccines for Children, Japan Market Share by Company, 2021-2026
    3.2 By Sales Quantity of Combination Vaccines for Children, Japan Market Share by Company, 2021-2026
    3.3 Japan Combination Vaccines for Children Combination Vaccines for Children Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
    4.1 Global Combination Vaccines for Children Capacity, Output and Capacity Utilization, 2021-2032
    4.2 Global Combination Vaccines for Children Capacity by Region
    4.3 Global Combination Vaccines for Children Production & Forecast by Region, 2021 VS 2025 VS 2032
    4.4 Global Combination Vaccines for Children Production by Region, 2021-2032
    4.5 Global Combination Vaccines for Children Production Market Share & Forecast by Region, 2021-2032
5 Industry Chain Analysis
    5.1 Combination Vaccines for Children Industry Chain
    5.2 Combination Vaccines for Children Upstream Analysis
        5.2.1 Combination Vaccines for Children Core Raw Materials
        5.2.2 Main Manufacturers of Combination Vaccines for Children Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Combination Vaccines for Children Production Mode
    5.6 Combination Vaccines for Children Procurement Model
    5.7 Combination Vaccines for Children Industry Sales Model and Sales Channels
        5.7.1 Combination Vaccines for Children Sales Model
        5.7.2 Combination Vaccines for Children Typical Distributors
6 Sights Combination Vaccines for Children Market Classification
    6.1 Combination Vaccines for Children Classification by Valence
        6.1.1 Bivalent Type
        6.1.2 Trivalent Type
        6.1.3 Multivalent Type (≥4 Valents)
        6.1.4 by Valence, Global Combination Vaccines for Children Consumption Value, 2021-2032
        6.1.5 by Valence, Global Combination Vaccines for Children Sales Quantity, 2021-2032
        6.1.6 by Valence, Global Combination Vaccines for Children Average Selling Price (ASP), 2021-2032
    6.2 Combination Vaccines for Children Classification by Pathogen Type
        6.2.1 Bacterial-Viral Combined
        6.2.2 Bacterial-Bacterial Combined
        6.2.3 Viral-Viral Combined
        6.2.4 by Pathogen Type, Global Combination Vaccines for Children Consumption Value, 2021-2032
        6.2.5 by Pathogen Type, Global Combination Vaccines for Children Sales Quantity, 2021-2032
        6.2.6 by Pathogen Type, Global Combination Vaccines for Children Average Selling Price (ASP), 2021-2032
    6.3 Combination Vaccines for Children Classification by Administration Route
        6.3.1 Intramuscular Injection
        6.3.2 Subcutaneous Injection
        6.3.3 Oral Combined
        6.3.4 by Administration Route, Global Combination Vaccines for Children Consumption Value, 2021-2032
        6.3.5 by Administration Route, Global Combination Vaccines for Children Sales Quantity, 2021-2032
        6.3.6 by Administration Route, Global Combination Vaccines for Children Average Selling Price (ASP), 2021-2032
7 Sights by Application
    7.1 Combination Vaccines for Children Segment by Application
        7.1.1 Routine Childhood Immunization
        7.1.2 Public Health
        7.1.3 Private Medical
    7.2 by Application, Global Combination Vaccines for Children Consumption Value & CAGR, 2021 VS 2025 VS 2032
    7.3 by Application, Global Combination Vaccines for Children Consumption Value, 2021-2032
    7.4 by Application, Global Combination Vaccines for Children Sales Quantity, 2021-2032
    7.5 by Application, Global Combination Vaccines for Children Price, 2021-2032
8 Sales Sights by Region
    8.1 By Region, Global Combination Vaccines for Children Consumption Value, 2021 VS 2025 VS 2032
    8.2 By Region, Global Combination Vaccines for Children Consumption Value, 2021-2032
    8.3 By Region, Global Combination Vaccines for Children Sales Quantity, 2021-2032
    8.4 North America
        8.4.1 North America Combination Vaccines for Children Market Size & Forecasts, 2021-2032
        8.4.2 By Country, North America Combination Vaccines for Children Market Size Market Share
    8.5 Europe
        8.5.1 Europe Combination Vaccines for Children Market Size & Forecasts, 2021-2032
        8.5.2 By Country, Europe Combination Vaccines for Children Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Combination Vaccines for Children Market Size & Forecasts, 2021-2032
        8.6.2 By Country/Region, Asia Pacific Combination Vaccines for Children Market Size Market Share
    8.7 South America
        8.7.1 South America Combination Vaccines for Children Market Size & Forecasts, 2021-2032
        8.7.2 By Country, South America Combination Vaccines for Children Market Size Market Share
    8.8 Middle East & Africa
9 Sales Sights by Country Level
    9.1 By Country, Global Combination Vaccines for Children Market Size & CAGR, 2021 VS 2025 VS 2032
    9.2 By Country, Global Combination Vaccines for Children Consumption Value, 2021-2032
    9.3 By Country, Global Combination Vaccines for Children Sales Quantity, 2021-2032
    9.4 United States
        9.4.1 United States Combination Vaccines for Children Market Size, 2021-2032
        9.4.2 by Valence, United States Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.4.3 by Application, United States Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
    9.5 Europe
        9.5.1 Europe Combination Vaccines for Children Market Size, 2021-2032
        9.5.2 by Valence, Europe Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.5.3 by Application, Europe Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
    9.6 China
        9.6.1 China Combination Vaccines for Children Market Size, 2021-2032
        9.6.2 by Valence, China Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.6.3 by Application, China Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
    9.7 Japan
        9.7.1 Japan Combination Vaccines for Children Market Size, 2021-2032
        9.7.2 by Valence, Japan Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.7.3 by Application, Japan Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
    9.8 South Korea
        9.8.1 South Korea Combination Vaccines for Children Market Size, 2021-2032
        9.8.2 by Valence, South Korea Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.8.3 by Application, South Korea Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
    9.9 Southeast Asia
        9.9.1 Southeast Asia Combination Vaccines for Children Market Size, 2021-2032
        9.9.2 by Valence, Southeast Asia Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.9.3 by Application, Southeast Asia Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
    9.10 India
        9.10.1 India Combination Vaccines for Children Market Size, 2021-2032
        9.10.2 by Valence, India Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.10.3 by Application, India Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Combination Vaccines for Children Market Size, 2021-2032
        9.11.2 by Valence, Middle East & Africa Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
        9.11.3 by Application, Middle East & Africa Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
10 Manufacturers Profile
    10.1 GlaxoSmithKline (GSK)
        10.1.1 GlaxoSmithKline (GSK) Company Information, Head Office, Market Area, and Industry Position
        10.1.2 GlaxoSmithKline (GSK) Combination Vaccines for Children Models, Specifications, and Application
        10.1.3 GlaxoSmithKline (GSK) Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.1.4 GlaxoSmithKline (GSK) Company Profile and Main Business
        10.1.5 GlaxoSmithKline (GSK) Recent Developments
    10.2 Merck
        10.2.1 Merck Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Merck Combination Vaccines for Children Models, Specifications, and Application
        10.2.3 Merck Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.2.4 Merck Company Profile and Main Business
        10.2.5 Merck Recent Developments
    10.3 KM Biologics
        10.3.1 KM Biologics Company Information, Head Office, Market Area, and Industry Position
        10.3.2 KM Biologics Combination Vaccines for Children Models, Specifications, and Application
        10.3.3 KM Biologics Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.3.4 KM Biologics Company Profile and Main Business
        10.3.5 KM Biologics Recent Developments
    10.4 Walvax Biotechnology
        10.4.1 Walvax Biotechnology Company Information, Head Office, Market Area, and Industry Position
        10.4.2 Walvax Biotechnology Combination Vaccines for Children Models, Specifications, and Application
        10.4.3 Walvax Biotechnology Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.4.4 Walvax Biotechnology Company Profile and Main Business
        10.4.5 Walvax Biotechnology Recent Developments
    10.5 Biokangtai
        10.5.1 Biokangtai Company Information, Head Office, Market Area, and Industry Position
        10.5.2 Biokangtai Combination Vaccines for Children Models, Specifications, and Application
        10.5.3 Biokangtai Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.5.4 Biokangtai Company Profile and Main Business
        10.5.5 Biokangtai Recent Developments
    10.6 Sinovac
        10.6.1 Sinovac Company Information, Head Office, Market Area, and Industry Position
        10.6.2 Sinovac Combination Vaccines for Children Models, Specifications, and Application
        10.6.3 Sinovac Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.6.4 Sinovac Company Profile and Main Business
        10.6.5 Sinovac Recent Developments
    10.7 Sanofi
        10.7.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
        10.7.2 Sanofi Combination Vaccines for Children Models, Specifications, and Application
        10.7.3 Sanofi Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.7.4 Sanofi Company Profile and Main Business
        10.7.5 Sanofi Recent Developments
    10.8 Serum Institute of India
        10.8.1 Serum Institute of India Company Information, Head Office, Market Area, and Industry Position
        10.8.2 Serum Institute of India Combination Vaccines for Children Models, Specifications, and Application
        10.8.3 Serum Institute of India Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.8.4 Serum Institute of India Company Profile and Main Business
        10.8.5 Serum Institute of India Recent Developments
    10.9 Biological E.
        10.9.1 Biological E. Company Information, Head Office, Market Area, and Industry Position
        10.9.2 Biological E. Combination Vaccines for Children Models, Specifications, and Application
        10.9.3 Biological E. Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.9.4 Biological E. Company Profile and Main Business
        10.9.5 Biological E. Recent Developments
    10.10 Panacea Biotec
        10.10.1 Panacea Biotec Company Information, Head Office, Market Area, and Industry Position
        10.10.2 Panacea Biotec Combination Vaccines for Children Models, Specifications, and Application
        10.10.3 Panacea Biotec Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.10.4 Panacea Biotec Company Profile and Main Business
        10.10.5 Panacea Biotec Recent Developments
    10.11 Bharat Biotech
        10.11.1 Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
        10.11.2 Bharat Biotech Combination Vaccines for Children Models, Specifications, and Application
        10.11.3 Bharat Biotech Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.11.4 Bharat Biotech Company Profile and Main Business
        10.11.5 Bharat Biotech Recent Developments
    10.12 LG Chem
        10.12.1 LG Chem Company Information, Head Office, Market Area, and Industry Position
        10.12.2 LG Chem Combination Vaccines for Children Models, Specifications, and Application
        10.12.3 LG Chem Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.12.4 LG Chem Company Profile and Main Business
        10.12.5 LG Chem Recent Developments
    10.13 PT Bio Farma
        10.13.1 PT Bio Farma Company Information, Head Office, Market Area, and Industry Position
        10.13.2 PT Bio Farma Combination Vaccines for Children Models, Specifications, and Application
        10.13.3 PT Bio Farma Combination Vaccines for Children Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.13.4 PT Bio Farma Company Profile and Main Business
        10.13.5 PT Bio Farma Recent Developments
11 Conclusion
12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Combination Vaccines for Children Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Combination Vaccines for Children Market Restraints
 Table 3. Combination Vaccines for Children Market Trends
 Table 4. Combination Vaccines for Children Industry Policy
 Table 5. Global Combination Vaccines for Children Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Combination Vaccines for Children Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Combination Vaccines for Children Sales Quantity by Company, (2021-2026) & (M Doses), Ranked Based on Sales in 2025
 Table 8. Global Combination Vaccines for Children Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
 Table 9. Global Combination Vaccines for Children Average Selling Price (ASP) by Company, (2021-2026) & (US$/Dose)
 Table 10. Global Combination Vaccines for Children Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 11. Global Combination Vaccines for Children Mergers & Acquisitions, Expansion Plans
 Table 12. Global Combination Vaccines for Children Manufacturers Product Type
 Table 13. Head Office and Combination Vaccines for Children Production Site of Key Manufacturer
 Table 14. Combination Vaccines for Children Capacity of Major Manufacturers and Future Plan
 Table 15. Japan Combination Vaccines for Children Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 16. Japan Combination Vaccines for Children Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 17. Japan Combination Vaccines for Children Sales Quantity by Company, (2021-2026) & (M Doses), Ranked Based on Sales in 2025
 Table 18. Japan Combination Vaccines for Children Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
 Table 19. Global Combination Vaccines for Children Production & Forecast by Region, 2021 VS 2025 VS 2032, (M Doses)
 Table 20. Global Combination Vaccines for Children Production by Region, 2021-2026, (M Doses)
 Table 21. Global Combination Vaccines for Children Production Forecast by Region, 2027-2032, (M Doses)
 Table 22. Global Key Players of Combination Vaccines for Children Upstream (Raw Materials)
 Table 23. Global Combination Vaccines for Children Typical Customers
 Table 24. Combination Vaccines for Children Typical Distributors
 Table 25. by Application, Global Combination Vaccines for Children Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 26. By Region, Global Combination Vaccines for Children Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 27. By Region, Global Combination Vaccines for Children Consumption Value, 2021-2032, US$ Million
 Table 28. By Region, Global Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Table 29. By Country, Global Combination Vaccines for Children Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 30. By Country, Global Combination Vaccines for Children Consumption Value, 2021-2032, US$ Million
 Table 31. By Country, Global Combination Vaccines for Children Consumption Value Market Share, 2021-2032
 Table 32. By Country, Global Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Table 33. By Country, Global Combination Vaccines for Children Sales Quantity Market Share, 2021-2032
 Table 34. GlaxoSmithKline (GSK) Company Information, Head Office, Market Area, and Industry Position
 Table 35. GlaxoSmithKline (GSK) Combination Vaccines for Children Models, Specifications, and Application
 Table 36. GlaxoSmithKline (GSK) Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 37. GlaxoSmithKline (GSK) Company Profile and Main Business
 Table 38. GlaxoSmithKline (GSK) Recent Developments
 Table 39. Merck Company Information, Head Office, Market Area, and Industry Position
 Table 40. Merck Combination Vaccines for Children Models, Specifications, and Application
 Table 41. Merck Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 42. Merck Company Profile and Main Business
 Table 43. Merck Recent Developments
 Table 44. KM Biologics Company Information, Head Office, Market Area, and Industry Position
 Table 45. KM Biologics Combination Vaccines for Children Models, Specifications, and Application
 Table 46. KM Biologics Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 47. KM Biologics Company Profile and Main Business
 Table 48. KM Biologics Recent Developments
 Table 49. Walvax Biotechnology Company Information, Head Office, Market Area, and Industry Position
 Table 50. Walvax Biotechnology Combination Vaccines for Children Models, Specifications, and Application
 Table 51. Walvax Biotechnology Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 52. Walvax Biotechnology Company Profile and Main Business
 Table 53. Walvax Biotechnology Recent Developments
 Table 54. Biokangtai Company Information, Head Office, Market Area, and Industry Position
 Table 55. Biokangtai Combination Vaccines for Children Models, Specifications, and Application
 Table 56. Biokangtai Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 57. Biokangtai Company Profile and Main Business
 Table 58. Biokangtai Recent Developments
 Table 59. Sinovac Company Information, Head Office, Market Area, and Industry Position
 Table 60. Sinovac Combination Vaccines for Children Models, Specifications, and Application
 Table 61. Sinovac Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 62. Sinovac Company Profile and Main Business
 Table 63. Sinovac Recent Developments
 Table 64. Sanofi Company Information, Head Office, Market Area, and Industry Position
 Table 65. Sanofi Combination Vaccines for Children Models, Specifications, and Application
 Table 66. Sanofi Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 67. Sanofi Company Profile and Main Business
 Table 68. Sanofi Recent Developments
 Table 69. Serum Institute of India Company Information, Head Office, Market Area, and Industry Position
 Table 70. Serum Institute of India Combination Vaccines for Children Models, Specifications, and Application
 Table 71. Serum Institute of India Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 72. Serum Institute of India Company Profile and Main Business
 Table 73. Serum Institute of India Recent Developments
 Table 74. Biological E. Company Information, Head Office, Market Area, and Industry Position
 Table 75. Biological E. Combination Vaccines for Children Models, Specifications, and Application
 Table 76. Biological E. Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 77. Biological E. Company Profile and Main Business
 Table 78. Biological E. Recent Developments
 Table 79. Panacea Biotec Company Information, Head Office, Market Area, and Industry Position
 Table 80. Panacea Biotec Combination Vaccines for Children Models, Specifications, and Application
 Table 81. Panacea Biotec Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 82. Panacea Biotec Company Profile and Main Business
 Table 83. Panacea Biotec Recent Developments
 Table 84. Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
 Table 85. Bharat Biotech Combination Vaccines for Children Models, Specifications, and Application
 Table 86. Bharat Biotech Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 87. Bharat Biotech Company Profile and Main Business
 Table 88. Bharat Biotech Recent Developments
 Table 89. LG Chem Company Information, Head Office, Market Area, and Industry Position
 Table 90. LG Chem Combination Vaccines for Children Models, Specifications, and Application
 Table 91. LG Chem Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 92. LG Chem Company Profile and Main Business
 Table 93. LG Chem Recent Developments
 Table 94. PT Bio Farma Company Information, Head Office, Market Area, and Industry Position
 Table 95. PT Bio Farma Combination Vaccines for Children Models, Specifications, and Application
 Table 96. PT Bio Farma Combination Vaccines for Children Sales Quantity (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin, 2021-2026
 Table 97. PT Bio Farma Company Profile and Main Business
 Table 98. PT Bio Farma Recent Developments


List of Figures
 Figure 1. Combination Vaccines for Children Picture
 Figure 2. Global Combination Vaccines for Children Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Global Combination Vaccines for Children Sales Quantity, (M Doses) & (2021-2032)
 Figure 4. Global Combination Vaccines for Children Average Selling Price (ASP), (2021-2032) & (US$/Dose)
 Figure 5. Japan Combination Vaccines for Children Consumption Value, (US$ million) & (2021-2032)
 Figure 6. Japan Combination Vaccines for Children Sales Quantity (M Doses) & (2021-2032)
 Figure 7. Japan Combination Vaccines for Children Average Selling Price (ASP), (US$/Dose) & (2021-2032)
 Figure 8. By Consumption Value, Japan Combination Vaccines for Children Market Share of Global, 2021-2032
 Figure 9. By Sales Quantity, Japan Combination Vaccines for Children Market Share of Global, 2021-2032
 Figure 10. Global Combination Vaccines for Children Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 11. Japan Combination Vaccines for Children Key Participants, Market Share, 2025
 Figure 12. Global Combination Vaccines for Children Capacity, Production and Capacity Utilization, 2021-2032
 Figure 13. Global Combination Vaccines for Children Capacity Market Share by Region, 2025 VS 2032
 Figure 14. Global Combination Vaccines for Children Production Market Share & Forecast by Region, 2021-2032
 Figure 15. Combination Vaccines for Children Industry Chain
 Figure 16. Combination Vaccines for Children Procurement Model
 Figure 17. Combination Vaccines for Children Sales Model
 Figure 18. Combination Vaccines for Children Sales Channels, Direct Sales, and Distribution
 Figure 19. Bivalent Type
 Figure 20. Trivalent Type
 Figure 21. Multivalent Type (≥4 Valents)
 Figure 22. by Valence, Global Combination Vaccines for Children Consumption Value, 2021-2032, US$ Million
 Figure 23. by Valence, Global Combination Vaccines for Children Consumption Value Market Share, 2021-2032
 Figure 24. by Valence, Global Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 25. by Valence, Global Combination Vaccines for Children Sales Quantity Market Share, 2021-2032
 Figure 26. by Valence, Global Combination Vaccines for Children Average Selling Price (ASP), 2021-2032, (US$/Dose)
 Figure 27. Bacterial-Viral Combined
 Figure 28. Bacterial-Bacterial Combined
 Figure 29. Viral-Viral Combined
 Figure 30. by Pathogen Type, Global Combination Vaccines for Children Consumption Value, 2021-2032, US$ Million
 Figure 31. by Pathogen Type, Global Combination Vaccines for Children Consumption Value Market Share, 2021-2032
 Figure 32. by Pathogen Type, Global Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 33. by Pathogen Type, Global Combination Vaccines for Children Sales Quantity Market Share, 2021-2032
 Figure 34. by Pathogen Type, Global Combination Vaccines for Children Average Selling Price (ASP), 2021-2032, (US$/Dose)
 Figure 35. Intramuscular Injection
 Figure 36. Subcutaneous Injection
 Figure 37. Oral Combined
 Figure 38. by Administration Route, Global Combination Vaccines for Children Consumption Value, 2021-2032, US$ Million
 Figure 39. by Administration Route, Global Combination Vaccines for Children Consumption Value Market Share, 2021-2032
 Figure 40. by Administration Route, Global Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 41. by Administration Route, Global Combination Vaccines for Children Sales Quantity Market Share, 2021-2032
 Figure 42. by Administration Route, Global Combination Vaccines for Children Average Selling Price (ASP), 2021-2032, (US$/Dose)
 Figure 43. Routine Childhood Immunization
 Figure 44. Public Health
 Figure 45. Private Medical
 Figure 46. by Application, Global Combination Vaccines for Children Consumption Value, 2021-2032, US$ Million
 Figure 47. by Application, Global Combination Vaccines for Children Revenue Market Share, 2021-2032
 Figure 48. by Application, Global Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 49. by Application, Global Combination Vaccines for Children Sales Quantity Market Share, 2021-2032
 Figure 50. by Application, Global Combination Vaccines for Children Price, 2021-2032, (US$/Dose)
 Figure 51. By Region, Global Combination Vaccines for Children Consumption Value Market Share, 2021-2032
 Figure 52. By Region, Global Combination Vaccines for Children Sales Quantity Market Share, 2021-2032
 Figure 53. North America Combination Vaccines for Children Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 54. By Country, North America Combination Vaccines for Children Consumption Value Market Share, 2025
 Figure 55. Europe Combination Vaccines for Children Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 56. By Country, Europe Combination Vaccines for Children Consumption Value Market Share, 2025
 Figure 57. Asia Pacific Combination Vaccines for Children Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 58. By Country/Region, Asia Pacific Combination Vaccines for Children Consumption Value Market Share, 2025
 Figure 59. South America Combination Vaccines for Children Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 60. By Country, South America Combination Vaccines for Children Consumption Value Market Share, 2025
 Figure 61. Middle East & Africa Combination Vaccines for Children Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 62. United States Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 63. by Valence, United States Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 64. by Application, United States Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 65. Europe Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 66. by Valence, Europe Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 67. by Application, Europe Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 68. China Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 69. by Valence, China Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 70. by Application, China Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 71. Japan Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 72. by Valence, Japan Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 73. by Application, Japan Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 74. South Korea Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 75. by Valence, South Korea Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 76. by Application, South Korea Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 77. Southeast Asia Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 78. by Valence, Southeast Asia Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 79. by Application, Southeast Asia Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 80. India Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 81. by Valence, India Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 82. by Application, India Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 83. Middle East & Africa Combination Vaccines for Children Sales Quantity, 2021-2032, (M Doses)
 Figure 84. by Valence, Middle East & Africa Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 85. by Application, Middle East & Africa Combination Vaccines for Children Sales Quantity Market Share, 2025 VS 2032
 Figure 86. Research Methodology
 Figure 87. Breakdown of Primary Interviews
 Figure 88. Bottom-up Approaches
 Figure 89. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有